| Value | ₹11.87 Cr |
|---|
BSE filing, NSE: ENTERO. Summary written from the filing by ALFA Finder's alert engine.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,665.00
- Market cap
- ₹7,254 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 57.8×Sector 54.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 2,087 Cr (+32.9% reported, +34.7% LFL), EBITDA Rs 111 Cr at 5.3% margin, PAT Rs 61 Cr (+66%). Strategy: consolidate fragmented distribution and scale MedTech (IVD, cardio-ortho).
Entero Healthcare Solutions Q2 FY27 Results: Net Profit ₹60.7 Cr, Up 65.8% YoY
Entero Healthcare Solutions Ltd reported revenue from operations of ₹2,087 Cr (+32.9% YoY) and net profit of ₹60.7 Cr (+65.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.7 Cr · +65.8% YoY
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.
Entero Healthcare Solutions Employee Stock Options
Entero Healthcare allotted 43,155 equity shares to employees upon exercise of stock options. The total consideration amounts to ₹4.24 Crore.
- Value
- ₹4.24 Cr
Other legal & regulatory announcements
All →Asian Star Company Legal & Regulatory
Asian Star Company received an Income Tax penalty order under Section 271G of Rs. 16.13 Crore. The company has appealed and expects no financial or operational impact.
- Value
- ₹16.13 Cr
Gufic BioSciences Legal & Regulatory
Gufic Biosciences disclosed an ITAT Mumbai order for AY 2023-24 that set aside the CIT(A) findings and restored the matter to the Assessing Officer. No demand arises from the order, and the tax liability will be determined after fresh assessment.
Vakrangee Legal & Regulatory
Vakrangee received Income Tax Department penalty orders of ₹60,703 for AY 2018-19 under section 270A. The company states the penalty has no material impact on its financials or operations.
- Value
- ₹0.01 Cr
Samtex Fashions Legal & Regulatory
Samtex Fashions disclosed a DRT-III demand notice and recovery certificate making it jointly liable for ₹437.57 Crore owed to NARCL via its wholly owned subsidiary SSA International. The company is evaluating the impact and legal remedies.
- Value
- ₹437.6 Cr
Physicswallah Legal & Regulatory
Physicswallah's board noted an NSE fine of Rs 2,000 for a one-day late shareholding pattern filing. The fine was later waived.
- Value
- ₹0.00 Cr
Goenka Business & Finance Legal & Regulatory
Goenka Business & Finance's demat accounts were unfrozen after an SAT stay on SEBI's 30 June 2026 order. The company had appealed that order.